Devalingam Mahalingam

Also affiliated with Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies”.

First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies

Journal of Hematology & Oncology(2025)10.1186/s13045-025-01753-8

N/A

0.436DataRank · unranked

14 citations

Minal Barve, Devalingam Mahalingam, Jay Parekh, Michael R. Kurman, James Strauss +10 more

Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer

Cancer Research(2021)10.1158/0008-5472.can-20-3595

N/A

0DataRank · unranked

48 citations

Alessandra Cunsolo, Meizhen Chen, Yusheng Qian, Chun-Lin Lin, Chia-Nung Hung +9 more

Phase II study of modulation of sorafenib (SOR)-induced autophagy using hydroxychloroquine (HCQ) in advanced hepatocellular cancer (HCC): Planned interim efficacy and safety analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.305

N/A

0DataRank · unranked

4 citations

Jennifer L. Moseley, Laura Tenner, Luisa Marie Arellano, Mary Salazar, Qianqian Liu +3 more

A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2-deficient advanced solid tumor malignancies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3104

N/A

0DataRank · unranked

3 citations

W. Kimryn Rathmell, Geoffrey I. Shapiro, Jordi Rodon Ahnert, Devalingam Mahalingam, Nikolaos A. Trikalinos +9 more

Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.237

N/A

0DataRank · unranked

1 citations

Michael C. Burns, Ryan Jones, Masha Kocherginsky, Kirsten B. Burdett, Guang‐Yu Yang +3 more

Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.12.003

N/A

0DataRank · unranked

4 citations

A. Martinez Bueno, Christophe Dooms, Komal Jhaveri, Maria de Miguel, Sarina A. Piha‐Paul +12 more

Phase 1 clinical trials in refractory colorectal cancer: Do older patients benefit?

Journal of Geriatric Oncology(2024)10.1016/j.jgo.2024.101816

N/A

0DataRank · unranked

0 citations

Devalingam Mahalingam, Colin Court, Norma Ketchum, Jonathan Gelfond, Joel Michalek +2 more

Data from Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer

(2023)10.1158/0008-5472.c.6512932.v1

N/A

0DataRank · unranked

0 citations

Alessandra Cunsolo, Meizhen Chen, Yusheng Qian, Chun-Lin Lin, Chia‐Nung Hung +9 more